The Latest Cardiac and Vascular News
Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2022 continues in Q1 2023 to date, with expectation of sales growth in 2023 PRINCETON, N.J., March 09, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive […]
CARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its fourth quarter and full year 2022 financial results on Thursday, March 16, 2023. In […]
– Topline results from ENLIVEN Phase 2b NASH trial on track for first quarter of 2023 – – Feedback from FDA supports advancement of Phase 3 program for pegozafermin in SHTG; plan to initiate first of two SHTG Phase 3 trials in the second quarter of 2023 – – Published results […]
WEST CHESTER, Pa., March 9, 2023 /PRNewswire/ — VESTECK, Inc. Scientific Advisory Board members along with Key Opinion Leaders from around the world, successfully completed the first 3 in human cases with the “SUTURE-TIGHT”TM catheter. Dr. Dai Yamanouchi and Professor Dainis Krievins successfully performed the first two endovascular aortic aneurysm repair (EVAR) procedures utilizing the “SUTURE-TIGHT”TM catheter in Riga, […]
TN-201 IND Cleared in January; Plan to Begin Phase 1b Dosing in MYBPC3-associated HCM Patients in Third Quarter 2023 Dosing Commenced in Multiple-Ascending Dose Stage of First-In-Human Clinical Trial of TN-301; Data Anticipated in Second Half 2023 2022 Year End Cash and Investments of $204 Million; Runway to Fund Operations into […]
CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (the “Company”) (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that it has entered into a securities purchase agreement (“Securities Purchase Agreement”) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (“Yorkville”), under which the Company agreed to […]
PARIS–(BUSINESS WIRE)–Regulatory News: Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Australia or Japan. This press release does not constitute an offering document and is for information purposes only. ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT – the “Company“), a clinical-stage biotechnology company […]
KENNEDY SPACE CENTER, Fla., March 8, 2023 /PRNewswire/ — Two tissue chip investigations funded by the National Institutes of Health (NIH) are among the payloads launching on SpaceX’s 27th Commercial Resupply Services (CRS) mission to the International Space Station (ISS). These projects, sponsored by the ISS National Laboratory, will study microgravity’s effects on engineered […]
Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study investigated the determinants of mechanical thrombectomy access for stroke globally WASHINGTON, March 8, 2023 /PRNewswire/ — The Society of Vascular and Interventional Neurology (SVIN) has released a first-ever global analysis of access to mechanical thrombectomy (MT) for treatment of large […]
The new unit at AdventHealth Tampa’s Pepin Heart Institute allows cardiologists to provide advanced therapies that improve outcomes for patients. TAMPA, Fla., March 8, 2023 /PRNewswire/ — AdventHealth Tampa announced a new 20-bed unit dedicated to patients diagnosed with heart failure. The disease affects one in five people over age 40, according […]
